222. 一次性ネフローゼ症候群 Primary nephrotic syndrome Clinical trials / Disease details

臨床試験数 : 310 / 薬物数 : 295 - (DrugBank : 117) / 標的遺伝子数 : 63 - 標的パスウェイ数 : 194

10 trials found

diseases per page:

Showing 1 to 10 of 10 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2013-000226-55-NL (EUCTR)	04/03/2015	24/06/2014	SEQUENTIAL THERAPY WITH TACROLIMUS AND RITUXIMAB IN PRIMARY MEMBRANOUS NEPHROPATHY	European Multicenter and Open-Label Controlled Randomized Trial to evaluate the Efficacy of Sequenti ...	Primary membranous nephropathy MedDRA version: 17.0;Level: LLT;Classification code 10027170;Term: Me ...	Trade Name: Tacrolimus Product Name: TACROLIMUS INN or Proposed INN: TACROLIMUS Other descriptive name: ...	Fundacion Renal Iñigo Alvarez Toledo	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	175		Spain;Netherlands
2	NCT01185197 (ClinicalTrials.gov)	September 2010	13/8/2010	Myfortic® for Minimal Change Nephrotic Syndrome (MCNS): a Randomized Study	Myfortic® Combined With Low-dose Steroid in Minimal Change Nephrotic Syndrome	Nephrosis, Lipoid	Drug: Myfortic plus low-dose steroid;Drug: Prednisolone	The University of Hong Kong	NULL	Completed	18 Years	65 Years	All	20	Phase 4	China
3	EUCTR2009-016003-26-GB (EUCTR)	06/05/2010	17/03/2010	RANDOMISED PILOT TRIAL OF MYFORTIC FOR THE TREATMENT OF PRIMARY PROTEINURIC GLOMERULONEPHRITIS. - Gl ...	RANDOMISED PILOT TRIAL OF MYFORTIC FOR THE TREATMENT OF PRIMARY PROTEINURIC GLOMERULONEPHRITIS. - Gl ...	Primary Proteinuric Glomeruolnephritis Focal segmental glomeruloscerosis and IgA nephropathy MedDRA ...	Trade Name: Myfortic Product Name: Myfortic 360mg Tablets INN or Proposed INN: mycophenolic acid Other d ...	UHB NHS Foundation Trust	NULL	Not Recruiting			Female: yes Male: yes	100	Phase 2	United Kingdom
4	ChiCTR-TRC-10001024	2008-01-01	2010-09-14	Tacrolimus versus Cyclophosphamide for Therapy in steroid-resistant and steroid-dependent primary fo ...	Tacrolimus versus Cyclophosphamide for Therapy in steroid-resistant and steroid-dependent primary fo ...	primary focal segmental glomerulosclerosis	group A:intravenous CTX 0.5-0.75g/m2 Monthly+Oral prednisone(Prednisolone) 0.8mg/kg.d ;group B:Oral ...	Shanghai Jiaotong University Affiliated Ruijin Hospital	NULL	Completed	18	75	Both	group A:30;group B:30;		China
5	JPRN-UMIN000000621	2007/03/01	28/02/2007	Okayama nephrotic syndrome treatment group: Study group for short-term combination therapy of angiot ...	Okayama nephrotic syndrome treatment group: Study group for short-term combination therapy of angiot ...	Minimal change nephrotic syndrome	Prednisolone (+), combination therapy (-) Prednisolone (+), combination therapy (+)	Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine, Dentist ...	NULL	Complete: follow-up complete	16years-old	Not applicable	Male and Female	50	Not selected	Japan
6	JPRN-C000000368	2004/04/01	27/03/2006	Multicenter study for combined therapy of prednisoloneand mizoribine in idiopathic membranous nephro ...	Multicenter study for combined therapy of prednisoloneand mizoribine in idiopathic membranous nephro ...	membranous nephropathy with primary steroid resistant nephrotic syndrome	mizoribineonce a day per os administration (150mg) after breakfast for 2years. mizoribine3 times a da ...	Project team for treatment of refractory nephrotic syndrome	The Progressive Renal Disease Research Projects in the Ministry of Health, Labor and Welfare, Japan	Complete: follow-up complete	16years-old	75years-old	Male and Female	100	Not selected	Japan
7	JPRN-C000000369	2004/04/01	27/03/2006	Multicenter study for combined therapy of prednisoloneand cyclosporin in refractory nephrotic syndro ...	Multicenter study for combined therapy of prednisoloneand cyclosporin in refractory nephrotic syndro ...	membranouos nephropathy and focal segmental glomerulosclerosis with primary steroid resistant nephro ...	CyA-MEPC once a day per os administration at 3mg/kgBW for 48 weeks CyA-MEPC twice a day per os admini ...	Project team for treatment of refractory nephrotic syndrome	The Progressive Renal Disease Research Projects in the Ministry of Health, Labor and Welfare, Japan	Complete: follow-up complete	16years-old	75years-old	Male and Female	300	Not selected	Japan
8	NCT00404833 (ClinicalTrials.gov)	January 2003	27/11/2006	Mycophenolate Mofetil in Membranous Nephropathy and Focal Segmental	A Prospective Randomized Open-label Study to Compare Mycophenolate Mofetil and Corticosteroid With C ...	Glomerulonephritis, Membranous;Glomerulosclerosis, Focal	Drug: prednisolone and mycophenolate mofetil;Drug: prednisolone and chlorambucil	Hospital Authority, Hong Kong	The University of Hong Kong	Completed	18 Years	65 Years	Both	16	Phase 3	China
9	JPRN-C000000379	2001/04/01	01/04/2006	Prednisoloneonly and a combination of prednisoloneand mizoribine for primary nephrotic syndrome rela ...	Prednisoloneonly and a combination of prednisoloneand mizoribine for primary nephrotic syndrome rela ...	Steroid-sensitive nephrotic syndrome	prednisolone mizoribine+prednisolone	Japanese Study Group of Renal Disease in Children(JSRDC)	NULL	Complete: follow-up complete	1years-old	10years-old	Male and Female	50	Not selected	Japan
10	EUCTR2015-001039-18-Outside-EU/EEA (EUCTR)		03/07/2015	Trial on the therapeutic effect of Tacrolimus in combination with low dosage corticosteroids compare ...	Open-Label, Randomized, Comparative, Multi-Center Clinical Trial on the Therapeutic Effect of Tacrol ...	Minimal change nephrotic syndrome;Therapeutic area: Diseases [C] - Immune System Diseases [C20]	Trade Name: Prograf INN or Proposed INN: TACROLIMUS Trade Name: Prograf INN or Proposed INN: TACROLIMUS ...	Astellas Pharma Korea, Inc.	NULL	NA			Female: yes Male: yes	152		Korea, Republic of

First Previous1Next Last